Jade Forrester
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jade Forrester has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Ben Thomas
Centre for Process Innovation (CPI), Coxon Building, John Walker Rd., Sedgefield, Stockton-on-Tees TS21 3FE, UK
1 shared publication - Callum George Davidson
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral St., Glasgow G4 0RE, Scotland, UK
1 shared publication - Chukwuebuka R. Obiora
Centre for Process Innovation (CPI), Coxon Building, John Walker Rd., Sedgefield, Stockton-on-Tees TS21 3FE, UK
1 shared publication - Daragh M. McLoughlin
Centre for Process Innovation (CPI), Coxon Building, John Walker Rd., Sedgefield, Stockton-on-Tees TS21 3FE, UK
1 shared publication - Heather Stockdale
Centre for Process Innovation (CPI), Coxon Building, John Walker Rd., Sedgefield, Stockton-on-Tees TS21 3FE, UK
1 shared publication - Lynn Donlon
Centre for Process Innovation (CPI), Coxon Building, John Walker Rd., Sedgefield, Stockton-on-Tees TS21 3FE, UK
1 shared publication
Latest Publications
- Open Access
- 25 April 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (5) , 566
Low-Cost Microfluidic Mixers: Are They up to the Task?
Background/Objectives: Microfluidic mixing has become the gold standard procedure for manufacturing nucleic acid lipid-based delivery systems, offering precise control over critical process parameters. The choice and design of microfluidic mixers are often seen as a key driving force affecting the critical quality attributes of the resulting lipid nanoparticles (LNPs). Methods: This study aimed to evaluate LNPs manufactured using two low-cost microfluidic mixers alongside manual mixing (pipette mixing (PM)), followed by characterization studies using orthogonal analytics as well as expression studies to establish whether low-cost microfluidic manufacturing methods are suitable for bench-scale and high-throughput research. Results: The results show that all manufacturing methods can produce LNPs with sizes ranging between 95 and 215 nm with high encapsulation (70–100%), and enhanced analytics showed variations between the LNPs produced using the different mixers. Despite these differences, pipette mixing production of LNPs demonstrated its application as a high-throughput screening tool for LNPs, effectively distinguishing between different formulations and predicting consistent expression patterns both in vitro and in vivo. Conclusions: Overall, these results validate the use of low-cost microfluidic mixers without compromising the efficiency and integrity of the resulting LNPs. This study supports the increased accessibility of small-scale LNP manufacturing and high-throughput screening.
- 25 April 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (5) , 566
Open AccessLow-Cost Microfluidic Mixers: Are They up to the Task?
Background/Objectives: Microfluidic mixing has become the gold standard procedure for manufacturing nucleic acid lipid-based delivery systems, offering precise control over critical process parameters. The choice and design of microfluidic mixers are often seen as a key driving force affecting the critical quality attributes of the resulting lipid nanoparticles (LNPs). Methods: This study aimed to evaluate LNPs manufactured using two low-cost microfluidic mixers alongside manual mixing (pipette mixing (PM)), followed by characterization studies using orthogonal analytics as well as expression studies to establish whether low-cost microfluidic manufacturing methods are suitable for bench-scale and high-throughput research. Results: The results show that all manufacturing methods can produce LNPs with sizes ranging between 95 and 215 nm with high encapsulation (70–100%), and enhanced analytics showed variations between the LNPs produced using the different mixers. Despite these differences, pipette mixing production of LNPs demonstrated its application as a high-throughput screening tool for LNPs, effectively distinguishing between different formulations and predicting consistent expression patterns both in vitro and in vivo. Conclusions: Overall, these results validate the use of low-cost microfluidic mixers without compromising the efficiency and integrity of the resulting LNPs. This study supports the increased accessibility of small-scale LNP manufacturing and high-throughput screening.